EC Healthcare Included as an Eligible Stock of the Shenzhen - Hong Kong Stock Connect Mar 07, 2022 12:45 HKT/SGT Read More
エーザイ、「レンビマ(R)」「キイトルーダ(R)」との併用療法について、治療ラインに関らず全身療法後に増悪した、根治的手術または放射線療法に不適応な進行性子宮内膜がんの適応で、台湾において承認を取得 Mar 07, 2022 11:50 JST Read More
Fujitsu and Tokyo Medical and Dental University leverage world's fastest supercomputer and AI technology for scientific discovery to shed light on drug resistance in cancer treatment Mar 07, 2022 09:21 HKT/SGT Read More
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets Mar 04, 2022 22:30 HKT/SGT Read More
Altamira Therapeutics 與 Nuance Pharma 優銳醫藥簽署獨家協議,在中國及部分亞洲市場共同開發和商業化Bentrio(TM) 鼻噴劑 Mar 04, 2022 22:30 HKT/SGT Read More
Altamira Therapeutics 与 Nuance Pharma 优锐医药签署独家协议,在中国及部分亚洲市场共同开发和商业化Bentrio(TM) 鼻喷剂 Mar 04, 2022 22:30 HKT/SGT Read More
Eisai Initiates Submission of Application Data Under the Prior Assessment Consultation System in Japan with the Aim of Obtaining Early Approval for Investigational Anti-Amyloid Beta Protofibril Antibody Lecanemab Mar 04, 2022 10:05 HKT/SGT Read More
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics Mar 02, 2022 20:47 HKT/SGT Read More